Multi-Omics Atlas of 30 Tissues Reveals How Aging Unfolds Across the Body
A landmark primate study maps aging across 30 tissues using transcriptomics, proteomics, and metabolomics — uncovering asynchronous tissue aging tied to translation efficiency.
Summary
Researchers profiled 30 tissues from 17 aging female rhesus macaques using transcriptome, proteome, and metabolome data to create a comprehensive molecular aging atlas. They found that while inflammation consistently increases across all tissues with age — mirroring findings in mice and humans — tissues do not age at the same rate or in the same way. Two distinct aging types were identified, with one type showing more pronounced aging linked to reduced mRNA translation efficiency. This more severely aging tissue group appears to drive whole-body aging disproportionately. Because rhesus macaques are evolutionarily close to humans and tissue sampling in people is difficult, this dataset offers an invaluable proxy for understanding human tissue aging at a molecular level.
Detailed Summary
Understanding how and why tissues age at different rates is one of the central challenges in longevity science. In humans, systematic multi-tissue sampling is ethically and logistically difficult, making high-quality animal models essential. Rhesus macaques, as close evolutionary relatives of humans, offer a uniquely translatable window into human aging biology.
In this study, published in Nature Methods, researchers generated and analyzed multi-omics data — transcriptome, proteome, and metabolome — from 30 distinct tissues collected from 17 female rhesus macaques ranging in age from 3 to 27 years. This broad tissue coverage and age range allowed the team to build one of the most comprehensive molecular aging atlases in a nonhuman primate to date.
A key universal finding was that inflammation increases with age across virtually all tissues studied, consistent with the 'inflammaging' concept supported by mouse and human research. However, the study's most striking result was that tissue aging is asynchronous — tissues do not age uniformly. The researchers classified tissue aging into two distinct types, with one category exhibiting significantly more pronounced molecular aging signatures than the other.
Critically, the more severely aging tissue type was associated with decreased mRNA translation efficiency — meaning aged cells in these tissues are less able to convert genetic instructions into functional proteins. This translationally impaired group of tissues appears to disproportionately contribute to systemic, whole-body aging, suggesting that boosting translation efficiency in key tissues could be a meaningful longevity target.
The study's primary caveat is that it was conducted entirely in females, limiting generalizability to male aging. Additionally, findings are correlational, and the causal role of translation efficiency in driving aging remains to be experimentally validated. Nonetheless, this atlas represents a foundational resource for aging biology research.
Key Findings
- Multi-omics data from 30 tissues across 17 female macaques aged 3–27 years created a comprehensive primate aging atlas.
- Inflammation increased consistently with age across all tissues, mirroring human and mouse aging data.
- Tissue aging is asynchronous and falls into two distinct types with differing severity.
- More pronounced tissue aging was strongly linked to decreased mRNA translation efficiency.
- The severely aging tissue group contributes disproportionately to whole-body aging trajectories.
Methodology
The study profiled transcriptome, proteome, and metabolome data from 30 tissues in 17 female rhesus macaques aged 3–27 years. A cross-sectional design was used, with tissues spanning major organ systems to enable broad tissue-level aging comparisons. Computational integration of three omics layers allowed identification of shared and tissue-specific aging signatures.
Study Limitations
The study included only female macaques, so findings may not fully apply to male aging biology. The cross-sectional design cannot establish causality between molecular changes and aging outcomes. Validation of translation efficiency as a causal aging driver requires future experimental intervention studies.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: